• Authors

Suggested:

Propanc Biopharma plans to acquire a digital asset finance company with a market capitalization below its net asset value.


2025-11-0413711 Views
On November 4th, according to Globenewswire, digital asset finance company Propanc Biopharma (NASDAQ stock code: PPCB) announced a strategic plan to acquire a digital asset management (DAT) company whose market value-to-net asset value (MNAV) is lower than its trading value. The company's management believes that acquiring undervalued digital asset technology (DAT) companies is an excellent opportunity to strengthen Propanc's balance sheet, achieve asset diversification, and create long-term shareholder value. These DAT companies typically hold a large amount of mainstream digital assets such as Bitcoin and Ethereum on their balance sheets. Propanc's board of directors and executive team are currently evaluating potential acquisition targets and developing a due diligence framework to assess balance sheet strength, digital asset holdings, and operational synergies.




Contact Us : ymxbxkr@gmail.com